Sio Gene Therapies Inc. Operating Lease Liability
Sio Gene Therapies Inc. had Operating Lease Liability of $2.52 million as of 2022-03-31, per its 10-K filed 2022-06-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2022-06-14
- 2022-03-31: Operating Lease, Liability $2.52M.
- 2021-03-31: Operating Lease, Liability $1.24M.
- 2020-12-31: Operating Lease, Liability $1.23M.
- 2020-09-30: Operating Lease, Liability $89.00K.
| Period end | Operating Lease, Liability |
|---|---|
| 2022-03-31 | $2.52M 10-K · filed 2022-06-14 |
| 2021-03-31 | $1.24M 10-K · filed 2021-06-09 |
| 2020-12-31 | $1.23M 10-Q · filed 2021-02-09 |
| 2020-09-30 | $89.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $535.00K 10-Q · filed 2020-08-11 |
| 2020-03-31 | $968.00K 10-K · filed 2020-06-10 |
| 2019-12-31 | $1.23M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $1.68M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $2.11M 10-Q · filed 2019-08-09 |